AI-DRIVEN

Decoding all diseases. Delivering precision.

We are a global specialist in AI- and data-driven precision medicine solutions.

Our platforms aims to help pharma, researchers, and clinicians deliver precision care—for every patient, in every disease.

Talk to Us

Built for the People

Who Shape

Healthcare

Our mission is to empower clinicians, researchers, and pharma companies with AI- and data-driven biomedical insights that enable personalized, predictive, and effective care for every patient.

By transforming complex biomedical data into clear, actionable intelligence, we help our partners make smarter decisions—from early discovery to real-world treatment.

Precision medicine isn’t coming. It’s happening—and Mavatar is leading the way.

Doctor

Technology that redefines

what’s possible in

medicine

Based on 20 years of research and continuous innovation, Mavatar is a global specialist in precision medicine solutions.

At the heart of our technology is DINA—a proprietary framework that analyzes vast biomedical datasets to reveal how diseases work and how patients respond to treatment.

But we’re not stopping there - using DINA, we also create digital twins—virtual models of diseases and patients that simulate treatment responses before anything is prescribed. It’s personalized medicine, powered by AI and real data.

Learn more about our Technical Foundation
Network

What we offer

Platform & Services.

Mavatar supports two distinct areas of healthcare—each built to empower a different kind of decision-maker.

Research & Drug Development Support

Our Mavatar Discovery platform is a self-service research platform that helps pharmaceutical companies, biotech firms, and academic researchers accelerate drug development and uncover new therapeutic insights. We also offer tailored services for pharma partners who need custom analysis and reporting.

Learn more

Personalized Treatment Support

Our Mavatar Precision platform supports doctors in making personalized treatment decisions through digital twin simulations—all with the aim of enabling smarter prescribing and better patient outcomes.Whether you're driving innovation in the lab or delivering care in the clinic, we have the tools to support you.

Learn more

Why Mavatar?

We're building the foundation for a new era of medicine—one where data drives discovery, and every decision is personalized, predictive, and precise. Rooted in deep science and designed for real-world scale, Mavatar is shaping the future of how we understand, treat, and ultimately prevent disease.

Proven Science, Proprietary Tech

Built on 20+ years of research our DINA framework delivers insights no other platform can—decoding disease biology at a systems level.

Precision at Every Step

From research to treatment, our two platforms —Mavatar Discovery and Mavatar Precision – turn complex data into smarter, faster, personalized decisions.

Digital Twins

Test treatments before they reach real patients. – Our digital twins simulate patient responses, improving trial design, patient selection, and success rates—while cutting costs.

Build for Real-World Impact

Already trusted by global pharma and public partners, Mavatar delivers measurable results: better outcomes, faster development, and less waste.

Partnership

Partner with Mavatar for transformative outcomes

A complete solution, combining cutting-edge AI-driven technology with hands-on collaboration from our team of 25+ PhDs in bioinformatics, genomics, and machine learning. By partnering with Mavatar, you gain a dedicated scientific partner committed to transforming research into real-world medical breakthroughs. Let’s shape the future of medicine together.

Get in touch

Collaborations

LATEST NEWS

Stay updated with our latest news and insights.

Go To Newsroom
JJ_Moving up the stair

27/04/2025 | NEWS

Mavatar lanserar stängd BETA av Mavatar Discovery – ny plattform för data-driven precisionsmedicin

Johan Juhlin_Davos

23/12/2024 | NEWS

Mavatar at the World Economic Forum in Davos

Mavatar Recognition_1

31/03/2025 | NEWS

Mavatar Recognized as One of Sweden’s Most Exciting AI Health Companies

Screenshot form Mavatar Discovery

27/03/2025 | NEWS

Revolutionizing Disease Research: Introducing Mavatar Discovery™️

Mavatar medicon village Juhlin presents

25/03/2025 | NEWS

Mavatar visits Medicon Village

Johan Juhlin image crossed arms

15/10/2024 | NEWS

Mavatar Secures SEK 40 Million in Partial Funding Round, Advancing its Leadership in AI-Driven Precision Medicine

Image of Linda Wakeham

02/12/2024 | NEWS

Mavatar Strengthens Leadership Team with Linda Wakeham as Head of Marketing & Communication

Join Beta